---
title: small lymphocytic lymphoma
alias: SLL
date: "2024-01-21"
enableToc: false
---

> [!info]
>
> ðŸŒ± ä¾†è‡ªï¼š[[leukemia]]

# small lymphocytic lymphoma

## Phase 3 multinational, randomized, double-blind study is designed to compare the efficacy and safety of the combination of ibrutinib and venetoclax vs. ibrutinib and placebo in subjects with MCL

1. Clinicaltrials.gov. Published 2024. Accessed January 21, 2024. <https://clinicaltrials.gov/study/NCT03112174>
